首页> 外国专利> METHOD FOR DIAGNOSING OR PREDICTING HEPATOCELLULAR CARCINOMA USING DNA METHYLATION CHANGES OF INTRAGENIC CPG ISLAND INVOLVED IN HEPATOCELLULAR CARCINOMA-SPECIFIC GENE EXPRESSION

METHOD FOR DIAGNOSING OR PREDICTING HEPATOCELLULAR CARCINOMA USING DNA METHYLATION CHANGES OF INTRAGENIC CPG ISLAND INVOLVED IN HEPATOCELLULAR CARCINOMA-SPECIFIC GENE EXPRESSION

机译:利用参与肝细胞癌特异性基因表达的内源性CPG岛的DNA甲基化变化诊断或预测肝细胞癌的方法

摘要

The present invention relates to a method for predicting or diagnosing hepatocellular carcinoma (HCC) using methylation changes of intragenic CpG island (intragenic CGI) involved in HCC-specific gene expression and, more specifically, to a method for predicting or diagnosing HCC using DNA methylation changes of intragenic CGI involved in the epigenetics during the HCC occurring process. According to the present invention, patient-customized treatments for HCC are possible based on association of DNA methylation changes of intragenic CGI involved in the epigenetics during the HCC occurring process, and races, sexes, ages and virus by patient group.;COPYRIGHT KIPO 2017
机译:本发明涉及利用参与HCC特异性基因表达的基因内CpG岛(基因内CGI)的甲基化变化来预测或诊断肝细胞癌(HCC)的方法,更具体地,涉及使用DNA甲基化来预测或诊断HCC的方法HCC发生过程中涉及表观遗传学的基因内CGI的变化。根据本发明,基于HCC发生过程中与表观遗传学有关的基因内CGI的DNA甲基化变化与种族,性别,年龄和病毒的关联,可以根据患者组对患者定制HCC治疗; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号